1-11 of 11
Yue Yang
Close
Sort by
Journal Articles

Genetic Deletion or Pharmacologic Inhibition of PTPN11 Impedes the Development and Progression of Myeloproliferative Neoplasms Induced By JAK2V617F and MPLW515L Mutants

Golam Mohi, Yue Yang, Mohammad A. Sayem, Bao T. Le, Fahim Ather, Avik Dutta, Salar Abbas
Journal: Blood
Blood (2023) 142 (Supplement 1): 739.
https://doi.org/10.1182/blood-2023-190216
Published: 2023
Journal Articles

PTPN1 Deficiency Accelerates the Progression to Myelofibrosis in JAK2V617F-Driven Myeloproliferative Neoplasm

Bao T. Le, Yue Yang, Golam Mohi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3855.
https://doi.org/10.1182/blood-2022-170621
Published: 2022
Journal Articles

Inhibition of SHP2 Ameliorates JAK2V617F-Induced Myeloproliferative Neoplasms

Yue Yang, Bao T. Le, Avik Dutta, Golam Mohi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1465.
https://doi.org/10.1182/blood-2021-152174
Published: 2021
Journal Articles

IL-1 Signaling Promotes Clonal Expansion and Progression of Bone Marrow Fibrosis in JAK2V617F-Induced Myeloproliferative Neoplasm

Mohammed Ferdous Ur Rahman, Yue Yang, Bao T. Le, Avik Dutta, Patrick Faughnan, Golam Mohi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2540.
https://doi.org/10.1182/blood-2021-147517
Published: 2021
Journal Articles

The RNA Splicing Factor U2AF1 Controls Hematopoietic Stem Cell Survival and Function

Avik Dutta, PhD, Yue Yang, PhD, Bao Le, Golam Mohi, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-143163
Published: 2020
Journal Articles

Critical Requirement of U2AF1 in the Maintenance and Function of Hematopoietic Stem Cells

Avik Dutta, PhD, Yue Yang, PhD, Bao Le, Golam Mohi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1195.
https://doi.org/10.1182/blood-2019-132007
Published: 2019
Journal Articles

The CDK6 Inhibitor Palbociclib in Combination with Ruxolitinib Remarkably Improves Myelofibrosis in Murine Models

Golam Mohi, PhD, Avik Dutta, PhD, Dipmoy Nath, PhD, Yue Yang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4200.
https://doi.org/10.1182/blood-2019-132038
Published: 2019
Journal Articles

The PIM Kinase Inhibitor TP-3654 in Combination with Ruxolitinib Exhibits Marked Improvement of Myelofibrosis in Murine Models

Dipmoy Nath, PhD, Avik Dutta, MSc, Yue Yang, BS, Clifford Whatcott, PhD, Steven L. Warner, PhD, Golam Mohi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 54.
https://doi.org/10.1182/blood-2018-99-119421
Published: 2018
Journal Articles

The NF-KB Inhibitor DMAPT in Combination with Ruxolitinib Displays Efficacy in Jak2V617F Knock-in Mouse Model of Myeloproliferative Neoplasms

Yue Yang, BS, Dipmoy Nath, PhD, Avik Dutta, MSc, Peter A Crooks, PhD, Golam Mohi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1783.
https://doi.org/10.1182/blood-2018-99-120195
Published: 2018
Journal Articles

Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm

Yue Yang, Hajime Akada, Dipmoy Nath, Robert E. Hutchison, Golam Mohi
Journal: Blood
Blood (2016) 127 (26): 3410–3423.
https://doi.org/10.1182/blood-2015-11-679431
Published: 2016
Includes: Supplemental data
Journal Articles

Loss of EZH2 Inhibits Erythropoiesis and Accelerates the Development of Myelofibrosis in Jak2V617F Knock-in Mice

Yue Yang, Hajime Akada, PhD, Dipmoy Nath, Robert E Hutchison, MD, Golam Mohi, PhD
Journal: Blood
Blood (2014) 124 (21): 159.
https://doi.org/10.1182/blood.V124.21.159.159
Published: 2014